BTAI - BioXcel Therapeutics Inc Dividends

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: INCR TLPH ZYBT CRDL DERM ANIK ASRT LFCR TKNO OPTH

| Held by: VTI VXF IWC BTEC

Scroll to Statements

Index	-
Market Cap	26.88M
Enterprise Value	109.99M
Income	-75.33M
Sales	0.68M
Book/sh	-3.90
Cash/sh	0.56
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Mar 08, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	39.53
P/B	-
P/C	1.56
P/FCF	-
EV/EBITDA	-
EV/Sales	161.75
Quick Ratio	0.61
Current Ratio	0.62
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-6.19
EPS next Y	-1.74
EPS next Q	-0.44
EPS this Y	66.84%
EPS next Y	8.42%
EPS next 5Y	48.34%
EPS past 3/5Y	60.75% 37.62%
Sales past 3/5Y	19.63% -
EPS Y/Y TTM	54.23%
Sales Y/Y TTM	-63.28%
EPS Q/Q	64.12%
Sales Q/Q	22.62%
Earnings	May 15 BMO
EPS/Sales Surpr.	-1.41% -46.00%

Insider Own	2.18%
Insider Trans	-5.57%
Inst Own	18.72%
Inst Trans	-0.69%
ROA	-207.56%
ROE	-
ROIC	-
Gross Margin	-5.15%
Oper. Margin	-7344.26%
Profit Margin	-11078.53%
SMA20	0.88%
SMA50	-18.82%
SMA200	-41.68%
Trades

Shs Outstand	30.88M
Shs Float	30.20M
Short Float	13.39%
Short Ratio	4.49
Short Interest	4.04M
52W High	8.08 -89.23%
52W Low	0.74 18.21%
Volatility	7.88% 12.22%
ATR (14)	0.08
RSI (14)	43.43
Beta	0.29
Rel Volume	1.03
Avg Volume	901.18K
Volume	199,271

Perf Week	3.03%
Perf Month	-20.85%
Perf Quarter	-30.90%
Perf Half Y	-44.90%
Perf YTD	-45.59%
Perf Year	-65.72%
Perf 3Y	-99.28%
Perf 5Y	-99.79%
Perf 10Y	-
Recom	2.50
Target Price	6.50
Prev Close	0.85
Price	0.87
Change	2.71%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)